BioMedWire Stocks Archives - Page 2 of 76

ThursdayFeb 12, 2026 10:00 am

Early Symptoms of Lung Cancer You Could Be Ignoring

Many times, a diagnosis of lung cancer comes late because the early symptoms may be dismissed since they are so subtle and can be mistaken for other illnesses. However, as with any other cancer, catching lung cancer early offers the best chance of getting better treatment outcomes. We explore some of those early warning signs that you may be downplaying. When you develop a cough that persists for several weeks, don’t be too quick to dismiss it as just an ordinary cough. Many times, that cough could be the result of an infection, an allergy, or pollution or be dismissed as “smoker’s cough.” However, it could also be pointing to something more serious, like lung cancer,…

TuesdayFeb 10, 2026 10:00 am

Why the Cost of Health Care in the US is Soaring

While people have been quick to blame health insurers for the skyrocketing cost of health care in the U.S., the reality of the situation is more nuanced, and other factors have played a much bigger role in driving up costs. We explore some of those less-reported drivers of the high cost of health care in the country. For example, the law caps the rates levied by medical facilities when treating patients on Medicare. However, private insurers aren’t constrained by these laws as they negotiate their rates directly with the health care facilities serving their clients. In order to be more appealing to patients on private insurance policies, hospitals are racing to upgrade…

FridayFeb 06, 2026 10:00 am

New Photodynamic Therapy Offers Hope Against Brain Cancer

A planned preclinical study testing a light-activated therapy that helps to kill residual brain cancer cells after a patient has undergone surgery to remove a tumor has elicited excitement as it could provide a way forward in eliminating microscopic cancer tissue that surgeons are unable to see while surgically removing a cancerous tumor from the brain. During this therapy, a catheter is inserted into the void left after the visible tumor is surgically removed. This catheter glows once the laser is switched on. The resultant light activates a drug that kills any cancer cells left inside the surrounding brain tissues. The drug is contained inside the…

ThursdayFeb 05, 2026 10:00 am

Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies

Researchers have developed a technological platform that leverages yeast cells to test and understand new cancer treatments under development. The use of this platform promises to significantly reduce the costs and time needed in the drug development process. Traditionally, immunotherapy treatments required several months to be tested in the lab. With this new method, the testing period could be collapsed to just a matter of days or a few weeks. The findings of this research appeared in the Nature Communications journal and feature the technology dubbed yeast surface display. The system involves using modified yeast cells to behave and respond in a similar way to the behavior and responses of immune…

TuesdayFeb 03, 2026 10:00 am

Policy Expert Offers Suggestions for Curbing US Health Care Costs

According to recent data, health expenditures in the U.S. reached $5.3 trillion in 2024. That figure equates to 18% of GDP, and is double what is spent on average in other developed countries. Americans are feeling the pinch, and an estimated 100 million individuals in the country have medical debt. This situation is unsustainable. While there is broad agreement that the health care system is in crisis, there are sharp divides on what solutions need to be implemented to fix the skyrocketing cost of health care in the U.S. Jordan Bruneau, the Great Lakes Policy Institute’s director, offers some recommendations that Americans themselves can implement without waiting for lawmakers and other…

FridayJan 30, 2026 10:00 am

New Compound Could Become a Transformational Brain Cancer Pill

Researchers at the University of Chicago have identified a compound that has shown efficacy in shrinking tumors in the brains of mice. This has created hope that the compound could, in future, be made into a pill that can treat glioblastoma, one of the deadliest forms of brain cancer. Hui Li, PhD, who led the study team, explains that compound A, as the substance is known, attached to a target on glioblastoma that hadn’t been known to serve as a therapeutic target. The researchers used mouse models in their study and they are now working to develop variants of compound A that are suitable for use in clinical trials. So far, 160 versions of this molecule…

ThursdayJan 29, 2026 10:00 am

Circadian Regulation Could Boost Cancer Immunotherapy, New Study Finds

Scientists have found that keeping circadian rhythms, the variations in body processes during the course of the day, in mind while administering immunotherapy could hold the key to boosting treatment outcomes in patients with cancer. The study, which was conducted by teams based at Zhujiang Hospital, Donghai County People’s Hospital and many other national research centers in China, involved conducting an integrated review of recent scientific studies on how circadian rhythms influence the microenvironment within tumors and in turn play a role in the outcomes of immunotherapy treatments, especially therapies aimed at blocking immune checkpoints. Immunotherapy has transformed cancer care in recent years, but the treatment’s effectiveness varies widely for…

FridayJan 23, 2026 10:00 am

Meta Analysis Finds That Weight Reduction Reduces Severity of Psoriasis

Psoriasis is a chronic skin condition that afflicts at least 60 million individuals globally. Nearly 80% of these affected people also tend to be either overweight or obese. Excess weight has been a known risk factor for psoriasis development, but until now, no rigorous scientific data existed on how the quality of life of patients and the disease severity are impacted when interventions to reduce weight are instituted for psoriatic patients. Now a meta-analysis and systematic review conducted in the UK has established that patients with psoriasis register notable improvements in their quality of life and the severity of the condition reduces when these patients undertake either lifestyle or pharmacological measures aimed at reducing…

ThursdayJan 22, 2026 10:00 am

New Digital Twin Predicts Outcomes of Brain Cancer Treatments

Researchers at the University of Michigan (U-M) have developed a system that leverages both AI and machine learning to create a digital twin of a patient’s brain cancer in order to predict how that patient will respond to different treatments. This tool promises to take personalized cancer care a step higher. The study, whose findings appeared in the journal Cell Metabolism, focused on gliomas. The team sought to establish how to distinguish between patients that are likely to benefit when their diets exclude certain amino acids (proteins) and those who are unlikely to benefit from such dietary changes. Some gliomas starve when these nutrients aren’t available in the food that a patient consumes, but some gliomas can “scavenge” for…

FridayJan 16, 2026 10:00 am

Experts are Astounded by the Vaccine Policy Change in the US

The recent vaccine policy changes that the U.S. government announced have astounded experts because the changes reduce recommended vaccines by one third and put the U.S. behinds its peer countries. This change shifts the U.S. from the position of leader on vaccination to a country that lags other developed nations on matters of disease prevention. This policy change marks the latest escalation of the HHS secretary, John F. Kennedy Jr., who has for long been a skeptic of vaccines and is now in a position where he can make policy decisions that affect the entire country. Daniel Jernigan, the National Center for Emerging Zoonotic Infectious Diseases’ former director,…